To the best of our knowledge, the research findings show, for the first time, that FBXW7 may not only directly ubiquitinate the mTOR protein, leading to mTOR protein degradation, but also decrease arginine production via metabolic reprogramming, suppressing mTOR pathway activation and consequently the occurrence and progression of CRC. The gene discussed is FBXW7; the disease is colorectal carcinoma.